1. Home
  2. BBSI vs SNDX Comparison

BBSI vs SNDX Comparison

Compare BBSI & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$36.80

Market Cap

887.4M

ML Signal

HOLD

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$20.96

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
SNDX
Founded
1965
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.4M
1.7B
IPO Year
1993
2016

Fundamental Metrics

Financial Performance
Metric
BBSI
SNDX
Price
$36.80
$20.96
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$45.50
$36.92
AVG Volume (30 Days)
207.1K
2.1M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
0.88%
N/A
EPS Growth
10.03
N/A
EPS
2.08
N/A
Revenue
$1,223,992,000.00
$111,304,000.00
Revenue This Year
$10.70
$620.14
Revenue Next Year
$7.58
$115.42
P/E Ratio
$17.56
N/A
Revenue Growth
9.64
595.65
52 Week Low
$33.01
$8.58
52 Week High
$49.65
$21.22

Technical Indicators

Market Signals
Indicator
BBSI
SNDX
Relative Strength Index (RSI) 54.29 68.24
Support Level $33.78 $20.00
Resistance Level $37.12 $21.22
Average True Range (ATR) 0.90 0.90
MACD 0.47 0.02
Stochastic Oscillator 91.78 85.48

Price Performance

Historical Comparison
BBSI
SNDX

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: